⌘K

Login Start Free

Home/Filings/4/0001181431-07-021088

4//SEC Filing

HALOZYME THERAPEUTICS INC 4

Accession 0001181431-07-021088

$HALOCIK 0001159036operating

View on SEC.gov Company Profile

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 4:15 PM ET

Size

21.1 KB

Accession

0001181431-07-021088

Insider Transaction Report

Form 4

Period: 2007-03-21

HALOZYME THERAPEUTICS INCHTI

Yocum Richard C

VP Clinical Development

Transactions

Exercise/Conversion
Common Stock
2007-03-21$1.87/sh+29,858$55,834→ 29,858 total
Sale
Common Stock
2007-03-22$8.46/sh−300$2,538→ 95,533 total
Exercise/Conversion
Option to Purchase Common Stock
2007-03-21$1.87/sh−29,858$55,834→ 188,118 total
Exercise: $1.87From: 2005-05-12Exp: 2015-05-12→ Common Stock (29,858 underlying)
Sale
Common Stock
2007-03-22$8.50/sh−17,900$152,150→ 69,075 total
Sale
Common Stock
2007-03-22$8.52/sh−2,600$22,152→ 66,475 total
Sale
Common Stock
2007-03-22$8.45/sh−8,300$70,135→ 87,233 total
Exercise/Conversion
Common Stock
2007-03-21$1.87/sh+65,975$123,373→ 95,833 total
Sale
Common Stock
2007-03-22$8.63/sh−200$1,726→ 65,975 total
Exercise/Conversion
Option to Purchase Common Stock
2007-03-21$1.87/sh−65,975$123,373→ 122,143 total
Exercise: $1.87From: 2005-05-12Exp: 2015-05-12→ Common Stock (65,975 underlying)
Sale
Common Stock
2007-03-22$8.49/sh−100$849→ 86,975 total
Sale
Common Stock
2007-03-22$8.47/sh−158$1,338→ 87,075 total

Documents

1 file

4
rrd152273.xmlPrimary
FORM 4 - YOCUM

Issuer

HALOZYME THERAPEUTICS INC

CIK 0001159036

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001159036

Filing Metadata

Form type: 4
Filed: Mar 22, 8:00 PM ET
Accepted: Mar 23, 4:15 PM ET
Size: 21.1 KB

View on SEC.gov